CIK 1012140

ONYX PHARMACEUTICALS INC

CIK 0001012140 · EDGAR ↗

cleanelevatedtriggeredno dataplanned

76.3

composite · 4 signals · ELEVATED

Every card below shows the score and the exact filing data it was computed from — no unexplained numbers. Some signals (P-02, P-03, P-08, P-09, P-10, P-11) pull live documents from SEC EDGAR the first time you view this company; a few of those (P-03, P-10, P-11) use AI to read the filing text, but every AI claim must quote the actual document verbatim or it's discarded — never a guess.

Chat with this filing →

Ask follow-up questions about the latest 10-K, with citations verified against the actual text. No account needed.

Investigation memo — generate one →

Run the bounded investigation agent — reads this company's signals and writes a short, cited summary.

Signals

P-05 · FY 2011-12-31 · ELEVATED92.6

Tax arbitrage

ETR 0.4% vs 21% statutory — gap persistent across 1 of 1 years

trend: flat

Trend

Source: 10-K on SEC.gov (filed 2013-02-28) ↗

Evidence — inputs and thresholds

{
  "etr_by_year": {
    "2011-12-31": 0.0036
  },
  "statutory_rate": 0.21,
  "gap_by_year": {
    "2011-12-31": 0.2064
  },
  "note": "Low ETR can be fully legitimate; this flags persistence + magnitude for review.",
  "stale": false,
  "latest_filing_period": "2012-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/0001047469-13-001966-index.htm",
    "form": "10-K",
    "filed": "2013-02-28"
  }
}

P-13 · FY 2012-12-31 · ELEVATED70.0

Zombie / distress

Interest coverage -12.26x below 1.0

trend: flat

Trend

Source: 10-K on SEC.gov (filed 2013-02-28) ↗

Evidence — inputs and thresholds

{
  "icr_by_year": {
    "2012-12-31": -12.26,
    "2011-12-31": 4.861,
    "2010-12-31": -3.522,
    "2009-12-31": 2.949
  },
  "consecutive_years_below_1": 1,
  "altman_z_double_prime": 6.358,
  "definitions": {
    "zombie": "ICR<1 for 3+ consecutive FYs (BIS 2018)",
    "z_distress": "<1.1 distress, 1.1-2.6 gray, >2.6 safe"
  },
  "inputs": {
    "ebit_t": -267087000,
    "interest_expense_t": 21785000
  },
  "stale": false,
  "latest_filing_period": "2012-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/0001047469-13-001966-index.htm",
    "form": "10-K",
    "filed": "2013-02-28"
  }
}

P-01 · FY 2012-12-31 · CLEAN20.1

Earnings quality

Beneish M-Score -2.80 — no manipulation profile

trend: flat

Trend

Source: 10-K on SEC.gov (filed 2013-02-28) ↗

Evidence — inputs and thresholds

{
  "m_score": -2.797,
  "threshold": -1.78,
  "ratios": {
    "DSRI": 1,
    "GMI": 1,
    "AQI": 1.009,
    "SGI": 0.81,
    "DEPI": 1.303,
    "SGAI": 1.648,
    "LVGI": 1.227,
    "TATA": 0
  },
  "defaulted_to_neutral": [
    "DSRI",
    "GMI",
    "TATA"
  ],
  "sloan_accruals": null,
  "inputs": {
    "revenue_t": 362165000,
    "revenue_t1": 447174000,
    "total_assets_t": 1351571000,
    "net_income_t": -187787000,
    "cfo_t": null
  },
  "stale": false,
  "latest_filing_period": "2012-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/0001047469-13-001966-index.htm",
    "form": "10-K",
    "filed": "2013-02-28"
  }
}

P-12 · FY 2012-12-31 · CLEAN24.5

Restatement predictor

F-Score 0.74 — at or below the population base rate

trend: flat

Trend

Source: 10-K on SEC.gov (filed 2013-02-28) ↗

Evidence — inputs and thresholds

{
  "f_score": 0.736,
  "probability": 0.00272,
  "components": {
    "rsst": null,
    "drec": 0.0573,
    "dinv": 0.0105,
    "soft": 0.8674,
    "dcs": -0.367,
    "droa": -0.1929,
    "issue": 0
  },
  "model": "Dechow et al. 2011, Model 1 (simplified RSST)",
  "thresholds": {
    "elevated": 1,
    "triggered": 1.85
  },
  "stale": false,
  "latest_filing_period": "2012-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1012140/000104746913001966/0001047469-13-001966-index.htm",
    "form": "10-K",
    "filed": "2013-02-28"
  }
}